Principles of bioactive lipid signalling: Lessons from sphingolipids

Nature Reviews Molecular Cell Biology

Volumn 9, Issue 2, 2008, Pages 139-150

  Hannun, Yusuf A ^a   Obeid, Lina M ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE; CERAMIDE 1 PHOSPHATE; SPHINGOLIPID; SPHINGOSINE; SPHINGOSINE 1 PHOSPHATE;

ANGIOGENESIS; CELL ADHESION; CELL FUNCTION; CELL GROWTH; CELL MIGRATION; CYTOLOGY; ENZYME REGULATION; INTRACELLULAR MEMBRANE; LIPID METABOLISM; PRIORITY JOURNAL; REVIEW; SENESCENCE;

ANIMALS; CELL PHYSIOLOGY; HUMANS; INFLAMMATION; LIPID METABOLISM; LIPIDS; LYSOPHOSPHOLIPIDS; MEMBRANE LIPIDS; MODELS, BIOLOGICAL; NEOVASCULARIZATION, PATHOLOGIC; SIGNAL TRANSDUCTION; SPHINGOLIPIDS; SPHINGOSINE;

EID: 38549152194     PISSN: 14710072     EISSN: 14710080     Source Type: Journal    
DOI: 10.1038/nrm2329     Document Type: Review

References (118)

1. 32P into phospholipids of pancreas slices. J. Biol. Chem. 203, 967-977 (1953). Earliest study to demonstrate agonist-induced turnover of inositol phospholipids.
2. Nishizuka, Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258, 607-614 (1992). An excellent review, by a pioneer in the field on bioactive lipids, that discusses the discovery of activation of PKC by DAG.
3. Serhan, C. N. & Savill, J. Resolution of inflammation: the beginning programs the end. Nature Immunol. 6, 1191-1197 (2005).
4. Smith, E. R., Merrill, A. H., Obeid, L. M. & Hannun, Y. A. Effects of sphingosine and other sphingolipids on protein kinase C. Methods Enzymol. 312, 361-373 (2000).
5. Obeid, L. M., Linardic, C. M., Karolak, L. A. & Hannun, Y. A. Programmed cell death induced by ceramide. Science 259, 1769-1771 (1993). A landmark study that implicated ceramide in apoptosis.
6. Venable, M. E., Lee, J. Y., Smyth, M. J., Bielawska, A. & Obeid, L. M. Role of ceramide in cellular senescence. J. Biol. Chem. 270, 30701-30708 (1995). The first study to implicate ceramide in cellular senescence.
7. Hla, T. Physiological and pathological actions of sphingosine 1-phosphate. Semin. Cell Dev. Biol. 15, 513-520 (2004).
8. Chalfant, C. E. & Spiegel, S. Sphingosine 1-phosphate and ceramide 1-phosphate: expanding roles in cell signaling. J. Cell Sci. 118, 4605-4612 (2005).
9. Mitsutake, S. et al. Ceramide kinase is a mediator of calcium-dependent degranulation in mast cells. J. Biol. Chem. 279, 17570-17577 (2004).
10. Hinkovska-Galcheva, V. et al. Ceramide 1-phosphate, a mediator of phagocytosis. J. Biol. Chem. 280, 26612-26621 (2005).
11. Radin, N. S., Shayman, J.A. & Inokuchi, J.-I. Metabolic effects of inhibiting glucosylceramide synthesis with PDMP and other substances. Adv. Lipid Res. 26, 183-211 (1993).
12. Gouaze-Andersson, V. & Cabot, M. C. Glycosphingolipids and drug resistance. Biochim. Biophys. Acta 1758, 2096-2103 (2006).
13. Hannun, Y. A. & Obeid, L. M. The ceramide-centric universe of lipid-mediated cell regulation: stress encounters of the lipid kind. J. Biol. Chem. 277, 25847-25850 (2002).
14. Linn, S. C. et al. Regulation of de novo sphingolipid biosynthesis and the toxic consequences of its disruption. Biochem. Soc. Trans. 29, 831-835 (2001).
15. Pewzner-Jung, Y., Ben-Dor, S. & Futerman, A. H. When do Lasses (longevity assurance genes) become CerS (ceramide synthases)?: insights into the regulation of ceramide synthesis. J. Biol. Chem. 281, 25001-25005 (2006).
16. Causeret, C., Geeraert, L., Van der Hoeven, G., Mannaerts, G. P. & van Veldhoven, P. P. Further characterization of rat dihydroceramide desaturase: tissue distribution, subcellular localization, and substrate specificity. Lipids 35, 1117-1125 (2000).
17. Wijesinghe, D. S. et al. Substrate specificity of human ceramide kinase. J. Lipid Res. 46, 2706-2716 (2005).
18. Raas-Rothschild, A., Pankova-Kholmyansky, I., Kacher, Y. & Futerman, A. H. Glycosphingolipidoses: beyond the enzymatic defect. Glycoconj. J. 21, 295-304 (2004).
19. Tafesse, F. G., Ternes, P. & Holthuis, J. C. The multigenic sphingomyelin synthase family. J. Biol. Chem. 281, 29421-29425 (2006).
20. Hakomori, S. Traveling for the glycosphingolipid path. Glycoconj. J. 17, 627-647 (2000).
21. Ichikawa, S. & Hirabayashi, Y. Glucosylceramide synthase and glycosphingolipid synthesis. Trends Cell Biol. 8, 198-202 (1998).
22. Marchesini, N. & Hannun, Y. A. Acid and neutral sphingomyelinases: roles and mechanisms of regulation. Biochem. Cell Biol. 82, 27-44 (2004).
23. Xu, R. et al. Golgi alkaline ceramidase regulates cell proliferation and survival by controlling levels of sphingosine and S1P. FASEB J. 20, 1813-1825 (2006).
24. Galadari, S. et al. Identification of a novel amidase motif in neutral ceramidase. Biochem. J. 393, 687-695 (2006).
25. Hait, N. C., Oskeritzian, C. A., Paugh, S. W., Milstien, S. & Spiegel, S. Sphingosine kinases, sphingosine 1-phosphate, apoptosis and diseases. Biochim. Biophys. Acta 1758, 2016-2026 (2006).
26. Johnson, K. R. et al. Role of human sphingosine-1-phosphate phosphatase 1 in the regulation of intra-and extracellular sphingosine-1- phosphate levels and cell viability. J. Biol. Chem. 278, 34541-34547 (2003).
27. Brindley, D. N. Lipid phosphate phosphatases and related proteins: signaling functions in development, cell division, and cancer. J. Cell Biochem. 92, 900-912 (2004).
28. Sigal, Y. J., McDermott, M. I. & Morris, A. J. Integral membrane lipid phosphatases/phosphotransferases: common structure and diverse functions. Biochem. J. 387, 281-293 (2005).
29. Bandhuvula, P. & Saba, J. D. Sphingosine-1-phosphate lyase in immunity and cancer: silencing the siren. Trends Mol. Med. 13, 210-217 (2007).
30. Bielawski, J., Szulc, Z. M., Hannun, Y. A. & Bielawska, A. Simultaneous quantitative analysis of bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry. Methods 39, 82-91 (2006).
31. Merrill, A. H. Jr, Sullards, M. C., Allegood, J. C., Kelly, S. & Wang, E. Sphingolipidomics: high-throughput, structure-specific, and quantitative analysis of sphingolipids by liquid chromatography tandem mass spectrometry. Methods 36, 207-224 (2005). A comprehensive and cutting-edge review on mass spectrometry methodology to analyse the sphingolipidome.
32. Romiti, E. et al. Characterization of sphingomyelinase activity released by thrombin-stimulated platelets. Mol. Cell. Biochem. 205, 75-81 (2000).
33. Delon, C. et al. Sphingosine kinase 1 is an intracellular effector of phosphatidic acid. J. Biol. Chem. 279, 44763-44774 (2004).
34. Lopez-Montero, I. et al. Rapid transbilayer movement of ceramides in phospholipid vesicles and in human erythrocytes. J. Biol. Chem. 280, 25811-25819 (2005).
35. Khan, W. A. et al. Use of D-erythro-sphingosine as a pharmacologic inhibitor of protein kinase C in human platelets. Biochem. J. 278, 387-392 (1991).
36. Xia, P. et al. Tumor necrosis factor-α induces adhesion molecule expression through the sphingosine kinase pathway. Proc. Natl Acad. Sci. USA 95, 14196-14201 (1998). An important study that first demonstrated the activation of sphingosine kinase by TNFα.
37. Pettus, B. J. et al. The sphingosine kinase 1/sphingosine-1- phosphate pathway mediates COX-2 induction and PGE2 production in response to TNF-α. FASEB J. 17, 1411-1421 (2003). An important study that implicates the SK1-S1P pathway in inflammation.
38. Hla, T., Lee, M. J., Ancellin, N., Paik, J. H. & Kluk, M. J. Lysophospholipids - receptor revelations. Science 294, 1875-1878 (2001).
39. Boujaoude, L. C. et al. Cystic fibrosis transmembrane regulator regulates uptake of sphingoid base phosphates and lysophosphatidic acid: modulation of cellular activity of sphingosine 1-phosphate. J. Biol. Chem. 276, 35258-35264 (2001).
40. Mitra, P. et al. Role of ABCC1 in export of sphingosine-1- phosphate from mast cells. Proc. Natl Acad. Sci. USA 103, 16394-16399 (2006).
41. Hanada, K. et al. Molecular machinery for nonvesicular trafficking of ceramide. Nature 426, 803-809 (2003). A breakthrough study on the discovery of ceramide transfer protein.
42. Fugmann, T. et al. Regulation of secretory transport by protein kinase D-mediated phosphorylation of the ceramide transfer protein. J. Cell Biol. 178, 15-22 (2007).
43. Chalfant, C. E., Szulc, Z., Roddy, P., Bielawska, A. & Hannun, Y. A. The structural requirements for ceramide activation of serine-threonine protein phosphatases. J. Lipid Res. 45, 496-506 (2004).
44. Dbaibo, G. et al. Rb as a downstream target for a ceramide-dependent pathway of growth arrest. Proc. Natl Acad. Sci. USA 92, 1347-1351 (1995).
45. Lee, J. Y., Hannun, Y. A. & Obeid, L. M. Ceramide inactivates cellular protein kinase Ca. J. Biol. Chem. 271, 13169-13174 (1996).
46. Zhou, H. L., Summers, S. K., Birnbaum, M. J. & Pittman, R. N. Inhibition of Akt kinase by cell-permeable ceramide and its implications for ceramide-induced apoptosis. J. Biol. Chem. 273, 16568-16575 (1998).
47. Müller, G. et al. PKCζ is a molecular switch in signal transduction of TNF-α, bifunctionally regulated by ceramide and arachidonic acid. EMBO J. 14, 1961-1969 (1995).
48. Bourbon, N. A., Sandirasegarane, L. & Kester, M. Ceramide-induced inhibition of Akt is mediated through protein kinase Cζ: implications for growth arrest. J. Biol. Chem. 277, 3286-3292 (2002).
49. Zhang, Y. H. et al. Kinase suppressor of Ras is ceramide-activated protein kinase. Cell 89, 63-72 (1997).
50. Heinrich, M. et al. Cathepsin D links TNF-induced acid sphingomyelinase to Bid-mediated caspase-9 and -3 activation. Cell Death Differ. 11, 550-563 (2004).
51. Wang, G. et al. Direct binding to ceramide activates protein kinase Cζ before the formation of a proapoptotic complex with PAR-4 in differentiating stem cells. J. Biol. Chem. 280, 26415-26424 (2005).
52. Okajima, F. Plasma lipoproteins behave as carriers of extracellular sphingosine 1-phosphate: is this an atherogenic mediator or an anti-atherogenic mediator? Biochim. Biophys. Acta 1582, 132-137 (2002).
53. Lee, M. J. et al. Sphingosine-1-phosphate as a ligand for the G protein coupled receptor EDG-1. Science 279, 1552-1555 (1998). The first study to identify and characterize an S1P receptor.
54. Bose, R. et al. Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signals. Cell 82, 405-414 (1995). An important study implicating ceramide synthase in chemotherapy-induced apoptosis.
55. Perry, D. K. et al. Serine palmitoyltransferase regulates de novo ceramide generation during etoposide-induced apoptosis. J. Biol. Chem. 275, 9078-9084 (2000).
56. Kroesen, B. J. et al. BcR-induced apoptosis involves differential regulation of C16 and C24-ceramide formation and sphingolipid-dependent activation of the proteasome. J. Biol. Chem. 278, 14723-14731 (2003).
57. Chalfant, C. E. et al. De novo ceramide regulates the alternative splicing of caspase 9 and Bcl-x in A549 lung adenocarcinoma cells. Dependence on protein phosphatase-1. J. Biol. Chem. 277, 12587-12595 (2002).
58. Merrill, A. H. Jr, Wang, E. & Mullins, R. E. Kinetics of long-chain (sphingoid) base biosynthesis in intact LM cells: effects of varying the extracellular concentrations of serine and fatty acid precursors of this pathway. Biochemistry 27, 340-345 (1988).
59. Cowart, L. A. & Hannun, Y. A. Selective substrate supply in the regulation of yeast de novo sphingolipid synthesis. J. Biol. Chem. 282, 12330-12340 (2007).
60. Dickson, R. C., Sumanasekera, C. & Lester, R. L. Functions and metabolism of sphingolipids in Saccharomyces cerevisiae. Prog. Lipid Res. 45, 447-465 (2006).
61. Chung, N., Mao, C., Heitman, J., Hannun, Y. A. & Obeid, L. M. Phytosphingosine as a specific inhibitor of growth and nutrient import in Saccharomyces cerevisiae. J. Biol. Chem. 276, 35614-35621 (2001).
62. Friant, S., Lombardi, R., Schmelzle, T., Hall, M. N. & Riezman, H. Sphingoid base signaling via Pkh kinases is required for endocytosis in yeast. EMBO J. 20, 6783-6792 (2001).
63. Meier, K. D., Deloche, O., Kajiwara, K., Funato, K. & Riezman, H. Sphingoid base is required for translation initiation during heat stress in Saccharomyces cerevisiae. Mol. Biol. Cell 17, 1164-1175 (2006).
64. Unger, R. H. Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome. Endocrinology 144, 5159-5165 (2003).
65. Holland, W. L. et al. Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. Cell Metab. 5, 167-179 (2007). An important study that implicates ceramide in insulin resistance.
66. Rotolo, J. A. et al. Caspase-dependent and -independent activation of acid sphingomyelinase signaling. J. Biol. Chem. 280, 26425-26434 (2005).
67. Lozano, J. et al. Cell autonomous apoptosis defects in acid sphingomyelinase knockout fibroblasts. J. Biol. Chem. 276, 442-448 (2001).
68. Garcia-Barros, M. et al. Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 300, 1155-1159 (2003).
69. Zeidan, Y. H., Wu, B. X., Jenkins, R. W., Obeid, L. M. & Hannun, Y. A. A novel role for protein kinase Cδ-mediated phosphorylation of acid sphingomyelinase in UV light-induced mitochondrial injury. FASEB J. 13 Aug 2007 (doi:10.1096/fj.07-8967com).
70. Grassme, H., Riehle, A., Wilker, B. & Gulbins, E. Rhinoviruses infect human epithelial cells via ceramide-enriched membrane platforms. J. Biol. Chem. 280, 26256-26262 (2005).
71. Zeidan, Y. H. et al. Acid ceramidase but not acid sphingomyelinase is required for tumor necrosis factor-a-induced PGE2 production. J. Biol. Chem. 281, 24695-24703 (2006).
72. Zeidan, Y. H. & Hannun, Y. A. Activation of acid sphingomyelinase by protein kinase Cδ-mediated phosphorylation. J. Biol. Chem. 282, 11549-11561 (2007).
73. Lin, T. et al. Role of acidic sphingomyelinase in Fas/CD95-mediated cell death. J. Biol. Chem. 275, 8657-8663 (2000).
74. Nix, M. & Stoffel, W. Perturbation of membrane microdomains reduces mitogenic signaling and increases susceptibility to apoptosis after T cell receptor stimulation. Cell Death Differ. 7, 413-424 (2000).
75. Castillo, S. S., Levy, M., Thaikoottathil, J. V. & Goldkorn, T. Reactive nitrogen and oxygen species activate different sphingomyelinases to induce apoptosis in airway epithelial cells. Exp. Cell Res. 313, 2680-2686 (2007).
76. Becker, K. P., Kitatani, K., Idkowiak-Baldys, J., Bielawski, J. & Hannun, Y. A. Selective inhibition of juxtanuclear translocation of protein kinase C βII by a negative feedback mechanism involving ceramide formed from the salvage pathway. J. Biol. Chem. 280, 2606-2612 (2005).
77. Clarke, C. J. et al. The extended family of neutral sphingomyelinases. Biochemistry 45, 11247-11256 (2006).
78. 2+-dependent neutral sphingomyelinase. Proc. Natl Acad. Sci. USA 97, 5895-5900 (2000).
79. Marchesini, N., Luberto, C. & Hannun, Y. A. Biochemical properties of mammalian neutral sphingomyelinase 2 and its role in sphingolipid metabolism. J. Biol. Chem. 278, 13775-13783 (2003).
80. Aubin, I. et al. A deletion in the gene encoding sphingomyelin phosphodiesterase 3 (Smpd3) results in osteogenesis and dentinogenesis imperfecta in the mouse. Nature Genet. 37, 803-805 (2005).
81. Stoffel, W. et al. Neutral sphingomyelinase (SMPD3) deficiency causes a novel form of chondrodysplasia and dwarfism that is rescued by Col2A1-driven smpd3 transgene expression. Am. J. Pathol. 171,153-161 (2007).
82. Karakashian, A. A., Giltiay, N. V., Smith, G. M. & Nikolova-Karakashian, M. N. Expression of neutral sphingomyelinase-2 (NSMase-2) in primary rat hepatocytes modulates IL-β-induced JNK activation. FASEB J. 18, 968-970 (2004).
83. De Palma, C., Meacci, E., Perrotta, C., Bruni, P. & Clementi, E. Endothelial nitric oxide synthase activation by tumor necrosis factor α through neutral sphingomyelinase 2, sphingosine kinase 1, and sphingosine 1 phosphate receptors: a novel pathway relevant to the pathophysiology of endothelium. Arterioscler. Thromb. Vasc. Biol. 26, 99-105 (2006).
84. Rutkute, K., Karakashian, A. A., Giltiay, N. V., Dobierzewska, A. & Nikolova-Karakashian, M. N. Aging in rat causes hepatic hyperresponsiveness to interleukin-1β which is mediated by neutral sphingomyelinase-2. Hepatology 46, 1166-1176 (2007). A crucial study that demonstrates a role for ceramide and sphingomyelin in ageing in vivo.
85. Clarke, C. J., Truong, T. G. & Hannun, Y. A. Role for neutral sphingomyelinase-2 in tumor necrosis factor α-stimulated expression of vascular cell adhesion molecule-1 (VCAM) and intercellular adhesion molecule-1 (ICAM) in lung epithelial cells: p38 MAPK is an upstream regulator of nSMase2. J. Biol. Chem. 282, 1384-1396 (2007).
86. Grimm, M. O. et al. Regulation of cholesterol and sphingomyelin metabolism by amyloid-â and presenilin. Nature Cell Biol. 7, 1118-1123 (2005).
87. Zeng, C. et al. Amyloid-β peptide enhances tumor necrosis factor-α-induced iNOS through neutral sphingomyelinase/ceramide pathway in oligodendrocytes. J. Neurochem. 94, 703-712 (2005).
88. Hayashi, Y., Kiyono, T., Fujita, M. & Ishibashi, M. cca1 is required for formation of growth-arrested confluent monolayer of rat 3Y1 cells. J. Biol. Chem. 272, 18082-18086 (1997).
89. Marchesini, N. et al. Role for mammalian neutral sphingomyelinase 2 in confluence-induced growth arrest of MCF7 cells. J. Biol. Chem. 279, 25101-25111 (2004).
90. Tani, M. & Hannun, Y. A. Analysis of membrane topology of neutral sphingomyelinase 2. FEBS Lett. 581, 1323-1328 (2007).
91. Spiegel, S. & Milstien, S. Sphingosine-1-phosphate: an enigmatic signalling lipid. Nature Rev. Mol. Cell Biol. 4, 397-407 (2003).
92. Johnson, K. R., Becker, K. P., Facchinetti, M. M., Hannun, Y. A. & Obeid, L. M. PKC-dependent activation of sphingosine kinase 1 and translocation to the plasma membrane. Extracellular release of sphingosine-1-phosphate induced by phorbol 12-myristate 13-acetate (PMA). J. Biol. Chem. 277, 35257-35262 (2002).
93. Melendez, A., Floto, R. A., Gillooly, D. J., Harnett, M. M. & Allen, J. M. FcaγRI coupling to phospholipase D initiates sphingosine kinase-mediated calcium mobilization and vesicular trafficking. J. Biol. Chem. 273, 9393-9402 (1998).
94. Pitson, S. M. et al. Activation of sphingosine kinase 1 by ERK1/2-mediated phosphorylation. EMBO J. 22, 5491-5500 (2003).
95. Taha, T. A., Argraves, K. M. & Obeid, L. M. Sphingosine-1-phosphate receptors: receptor specificity versus functional redundancy. Biochim. Biophys. Acta 1682, 48-55 (2004).
96. Xia, P. et al. Sphingosine kinase interacts with TRAF2 and dissects tumor necrosis factor-α signaling. J. Biol. Chem. 277, 7996-8003 (2002).
97. Billich, A. et al. Basal and induced sphingosine kinase 1 activity in A549 carcinoma cells: function in cell survival and IL-1β and TNF-α induced production of inflammatory mediators. Cell Signal. 17, 1203-1217 (2005).
98. Lee, M. J. et al. Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate. Cell 99, 301-312 (1999).
99. Liu, Y. et al. Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. J. Clin. Invest. 106, 951-961 (2000).
100. Mizugishi, K. et al. Essential role for sphingosine kinases in neural and vascular development. Mol. Cell. Biol. 25, 11113-11121 (2005).
101. Peters, S. L. & Alewijnse, A. E. Sphingosine-1-phosphate signaling in the cardiovascular system. Curr. Opin. Pharmacol. 7, 186-192 (2007).
102. Rosen, H., Sanna, G. & Alfonso, C. Egress: a receptorregulated step in lymphocyte trafficking. Immunol. Rev. 195, 160-177 (2003).
103. Gonsette, R. E. New immunosuppressants with potential implication in multiple sclerosis. J. Neurol. Sci. 223, 87-93 (2004).
104. Taha, T. A. et al. Loss of sphingosine kinase-1 activates the intrinsic pathway of programmed cell death: modulation of sphingolipid levels and the induction of apoptosis. FASEB J. 20, 482-484 (2006).
105. Pettus, B. J. et al. Ceramide 1-phosphate is a direct activator of cytosolic phospholipase A2. J. Biol. Chem. 279, 11320-11326 (2004).
106. 2+-dependent activation of ceramide kinase as a calcium sensor. J. Biol. Chem. 280, 40436-40441 (2005).
107. Gomez-Munoz, A. Ceramide 1-phosphate/ceramide, a switch between life and death. Biochim. Biophys. Acta 1758, 2049-2056 (2006).
108. Raggers, R. J., van Helvoort, A., Evers, R. & van Meer, G. The human multidrug resistance protein MRP1 translocates sphingolipid analogs across the plasma membrane. J. Cell Sci. 112, 415-422 (1999).
109. Schulz, A. et al. The CLN9 protein, a regulator of dihydroceramide synthase. J. Biol. Chem. 281, 2784-2794 (2006).
110. Kraveka, J. M. et al. Involvement of dihydroceramide desaturase in cell cycle progression in human neuroblastoma cells. J. Biol. Chem. 282, 16718-16728 (2007).
111. Zheng, W. et al. Ceramides and other bioactive sphingolipid backbones in health and disease: lipidomic analysis, metabolism and roles in membrane structure, dynamics, signaling and autophagy. Biochim. Biophys. Acta 1758, 1864-1884 (2006).
112. Ignatov, A. et al. Role of the G-protein-coupled receptor GPR12 as high-affinity receptor for sphingosylphosphorylcholine and its expression and function in brain development. J. Neurosci. 23, 907-914 (2003).
113. Zeidan, Y. H. & Hannun, Y. A. Translational aspects of sphingolipid metabolism. Trends Mol. Med. 13, 327-336 (2007).
114. Radin, N. S. Designing anticancer drugs via the achilles heel: ceramide, allylic ketones, and mitochondria. Bioorg. Med. Chem. 11, 2123-2142 (2003).
115. Summers, S. A. Ceramides in insulin resistance and lipotoxicity. Prog. Lipid Res. 45, 42-72 (2006).
116. Wattenberg, B. W., Pitson, S. M. & Raben, D. M. The sphingosine and diacylglycerol kinase superfamily of signaling kinases: localization as a key to signaling function. J. Lipid Res. 47, 1128-1139 (2006).
117. Alvarez-Vasquez, F. et al. Simulation and validation of modelled sphingolipid metabolism in Saccharomyces cerevisiae. Nature 433, 425-430 (2005).
118. D'Angelo, G. et al. Glycosphingolipid synthesis requires FAPP2 transfer of glucosylceramide. Nature 449, 62-67 (2007).